secwatch.observer — SEC 8-K summary
======================================

Issuer:     Nuwellis, Inc. (NUWE)
CIK:        0001506492
Form:       8-K
Filed at:   2023-12-13T23:59:59+00:00
Accession:  0001140361-23-057477
Event type: regulatory
Sentiment:  negative
Materiality: 0.75
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Nuwellis (NUWE) receives Nasdaq minimum bid price deficiency notice; 180-day cure period until June 4, 2024
--------------------------------------------------------------------------------

- Closing bid price below $1.00 for 30 consecutive trading days triggered Nasdaq deficiency notice on Dec 7, 2023.
- Cure period ends June 4, 2024; must close at $1.00 or higher for 10 consecutive trading days to regain compliance.
- If not cured by June 4, may qualify for second 180-day period if meeting other listing standards and notifying intent to cure.
- Company considering options including reverse stock split; delisting risk remains if not compliant.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1506492/000114036123057477/0001140361-23-057477-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1506492/000114036123057477/ef20016446_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-23-057477

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer